An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
Clinical trial NCT06927999 · RECRUITING
Trial details
- NCT number
- NCT06927999
- Sponsor
- ARS Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-09
- Primary completion
- 2027-06-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.